Mark Elliott Boulding - 01 Feb 2022 Form 4 Insider Report for PTC THERAPEUTICS, INC. (PTCT)

Role
Exec. VP and CLO
Signature
/s/ Avraham S. Adler, attorney-in-fact
Issuer symbol
PTCT
Transactions as of
01 Feb 2022
Net transactions value
-$31,162
Form type
4
Filing time
03 Feb 2022, 15:57:37 UTC
Previous filing
11 Jan 2022
Next filing
11 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTCT Common Stock Sale $31,162 -779 -1.3% $40.00 61,110 01 Feb 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 2,550 RSUs from a January 29, 2020 grant of 10,200 RSUs.